Chemicals · Founded 2018 · www.gfl.co.in · BSE 542812 · NSE FLUOROCHEM · ISIN INE09N301011
No Notes Added Yet
Business
Gujarat Fluorochemicals Ltd. (GFL) is a leading Indian chemical manufacturer with a diversified portfolio focused primarily on fluorochemicals. The company is backward integrated, producing key raw materials like Hydrofluoric Acid (HF) from fluorspar. Its core business involves manufacturing and selling a range of products including refrigerants (HFCs, HFOs), fluoropolymers (PTFE, PFA, FEP, etc.), specialty chemicals for agrochemical and pharmaceutical industries, and caustic soda. GFL makes money by manufacturing these value-added chemicals and selling them to diverse end-use industries globally, including HVAC, automotive, electronics, construction, renewable energy, and life sciences.
Revenue Mix
While exact revenue contributions can fluctuate and are often reported comprehensively, GFL's primary business segments are:
Fluoropolymers: This segment includes products like PTFE, FEP, PFA, and other advanced fluoropolymers, serving critical applications in industries such as electrical, electronics, automotive (EVs), renewable energy, and industrial coatings.
Refrigerants: GFL manufactures various generations of refrigerants, including HFCs and newer generation low GWP (Global Warming Potential) refrigerants (HFOs). These are used in air conditioning, refrigeration, and automotive sectors.
Caustic Soda: A basic inorganic chemical used in various industries, including textile, paper, aluminum, and soap manufacturing.
Specialty Chemicals: This segment caters to specific requirements of the pharmaceutical and agrochemical industries, providing intermediates and performance chemicals.
Industry
GFL operates within the broad chemicals sector, with a significant focus on the fluorochemicals industry, which is a specialized and technology-intensive segment. The fluorochemical industry is characterized by complex manufacturing processes and high entry barriers. GFL is one of the few integrated players globally, and a prominent manufacturer of fluoropolymers and refrigerants in India. It competes with global majors and other domestic players, positioning itself through backward integration, R&D capabilities, and a diversified product portfolio, especially in the growing advanced fluoropolymer and new-generation refrigerant markets.
MOAT
Backward Integration: GFL is significantly backward integrated, producing critical raw materials like Hydrofluoric Acid (HF) from fluorspar. This provides cost advantages, supply chain reliability, and reduces dependency on external suppliers, especially for key intermediates in fluorochemical production.
R&D and Product Diversification: The company invests in R&D to develop new grades of fluoropolymers and specialty chemicals, enabling it to cater to evolving customer needs and high-value applications, offering a wider product basket.
Global Presence & Scale: GFL has a strong presence in international markets and operates at a scale that allows for cost efficiencies in production and distribution.
Technological Expertise: Extensive experience and technical know-how in complex fluorochemical manufacturing processes.
Growth Drivers
Demand for Fluoropolymers in Sunrise Sectors: Growing demand from electric vehicles (EVs), 5G technology, solar energy, electronics, and medical applications due to fluoropolymers' unique properties (heat resistance, chemical inertness).
Transition to Low GWP Refrigerants: Global environmental regulations phasing down high GWP refrigerants (HFCs) are driving demand for new-generation, low GWP refrigerants (HFOs), where GFL has a developing portfolio.
Specialty Chemicals Growth: Sustained demand from the pharmaceutical and agrochemical sectors for custom synthesis and intermediates.
Capacity Expansion: Ongoing capital expenditure to expand capacities across various product lines will support increased sales volumes.
Exports: Increasing global demand for GFL's specialized products, particularly fluoropolymers.
Risks
Raw Material Price Volatility: Fluctuations in the prices of key raw materials like fluorspar, caustic soda, and energy can impact profitability.
Regulatory Changes: Stringent environmental regulations, refrigerant phase-down schedules, and anti-dumping duties in different geographies can affect operations and demand.
Economic Slowdown: A downturn in global or domestic economies can reduce demand from end-user industries such as automotive, construction, and consumer durables.
Intense Competition: Competition from domestic and international chemical manufacturers can put pressure on pricing and margins.
Foreign Exchange Fluctuations: Given significant exports and imports, currency volatility can impact revenue and costs.
Project Execution Risk: Delays or cost overruns in ongoing or future capital expenditure projects.
Management & Ownership
Gujarat Fluorochemicals Ltd. is part of the Inox Group, with promoter families holding a significant stake in the company. The management team includes experienced professionals with long-standing involvement in the chemical industry. The promoter group has a history in various industrial sectors, including chemicals, industrial gases, and entertainment. The ownership structure is primarily promoter-led, ensuring alignment of long-term interests.
Outlook
GFL is well-positioned in the specialty chemicals and fluorochemicals space, benefiting from its integrated operations and diversified product portfolio. The company is likely to see demand driven by sunrise sectors like EVs, electronics, and renewable energy, which favor high-performance fluoropolymers, and the global transition towards low GWP refrigerants. However, the business is susceptible to commodity price volatility for raw materials, the cyclicality of end-user industries, and evolving environmental regulations. Successful execution of capacity expansion projects and effective management of global competitive pressures will be critical for sustained growth and profitability.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 992 | 1133 | 1176 | 1188 | 1148 | 1225 | 1281 | 1210 | 1136 | 1369 |
| Other Income | 13 | 27 | 9 | 9 | 14 | 26 | 23 | 6 | 7 | 6 |
| Total Income | 1005 | 1160 | 1185 | 1197 | 1162 | 1251 | 1304 | 1216 | 1143 | 1375 |
| Total Expenditure | 786 | 904 | 914 | 893 | 854 | 919 | 937 | 846 | 861 | 1061 |
| Operating Profit | 219 | 256 | 271 | 304 | 308 | 332 | 367 | 370 | 282 | 314 |
| Interest | 37 | 34 | 37 | 42 | 42 | 26 | 30 | 33 | 33 | 42 |
| Depreciation | 72 | 81 | 85 | 90 | 91 | 89 | 90 | 91 | 89 | 97 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -17 | -3 |
| Profit Before Tax | 110 | 141 | 149 | 172 | 175 | 217 | 247 | 246 | 143 | 172 |
| Provision for Tax | 30 | 40 | 41 | 51 | 49 | 26 | 63 | 67 | 41 | 62 |
| Profit After Tax | 80 | 101 | 108 | 121 | 126 | 191 | 184 | 179 | 102 | 110 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
| Profit After Adjustments | 80 | 101 | 108 | 121 | 126 | 191 | 184 | 179 | 103 | 112 |
| Adjusted Earnings Per Share | 7.3 | 9.2 | 9.8 | 11 | 11.5 | 17.4 | 16.7 | 16.3 | 9.4 | 10.2 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Net Sales | 2606 | 2650 | 3954 | 5685 | 4281 | 4737 | 4996 |
| Other Income | 216 | 207 | 162 | 173 | 107 | 116 | 42 |
| Total Income | 2823 | 2858 | 4115 | 5858 | 4388 | 4853 | 5038 |
| Total Expenditure | 2167 | 2061 | 2786 | 3720 | 3373 | 3639 | 3705 |
| Operating Profit | 655 | 797 | 1329 | 2138 | 1014 | 1215 | 1333 |
| Interest | 105 | 113 | 78 | 117 | 133 | 147 | 138 |
| Depreciation | 192 | 202 | 205 | 236 | 286 | 355 | 367 |
| Exceptional Income / Expenses | -26 | 0 | 0 | 0 | 0 | 0 | -20 |
| Profit Before Tax | 332 | 482 | 1045 | 1785 | 595 | 713 | 808 |
| Provision for Tax | 143 | 704 | 269 | 462 | 160 | 167 | 233 |
| Profit After Tax | 189 | -222 | 776 | 1323 | 435 | 546 | 575 |
| Adjustments | 7 | 3 | 11 | 6 | 0 | 0 | 3 |
| Profit After Adjustments | 196 | -219 | 787 | 1329 | 435 | 546 | 578 |
| Adjusted Earnings Per Share | 17.9 | -19.9 | 71.7 | 121 | 39.6 | 49.7 | 52.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 11% | 6% | 13% | 0% |
| Operating Profit CAGR | 20% | -3% | 13% | 0% |
| PAT CAGR | 26% | -11% | 24% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -3% | 4% | 27% | NA% |
| ROE Average | 8% | 14% | 11% | 10% |
| ROCE Average | 10% | 16% | 16% | 15% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Shareholder's Funds | 3716 | 3493 | 4255 | 5521 | 5936 | 7253 |
| Minority's Interest | -11 | -14 | -25 | 0 | 0 | 46 |
| Borrowings | 479 | 392 | 435 | 183 | 373 | 397 |
| Other Non-Current Liabilities | -198 | 309 | 306 | 328 | 421 | 385 |
| Total Current Liabilities | 1843 | 1789 | 1906 | 2339 | 2503 | 2523 |
| Total Liabilities | 5828 | 5969 | 6878 | 8371 | 9233 | 10602 |
| Fixed Assets | 2404 | 2357 | 2507 | 3108 | 4261 | 4282 |
| Other Non-Current Assets | 1498 | 1688 | 1932 | 1765 | 1569 | 2038 |
| Total Current Assets | 1927 | 1904 | 2438 | 3471 | 3404 | 4283 |
| Total Assets | 5828 | 5969 | 6878 | 8371 | 9233 | 10602 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 17 | 12 | 26 | 24 | 31 |
| Cash Flow from Operating Activities | 546 | 616 | 741 | 739 | 626 | 545 |
| Cash Flow from Investing Activities | -1192 | -373 | -584 | -476 | -966 | -1121 |
| Cash Flow from Financing Activities | 622 | -248 | -144 | -264 | 348 | 599 |
| Net Cash Inflow / Outflow | -24 | -5 | 14 | -2 | 7 | 24 |
| Closing Cash & Cash Equivalent | 17 | 12 | 26 | 24 | 31 | 55 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 17.87 | -19.91 | 71.66 | 120.97 | 39.58 | 49.69 |
| CEPS(Rs) | 34.75 | -1.77 | 89.33 | 141.93 | 65.61 | 81.95 |
| DPS(Rs) | 0 | 0 | 4 | 4 | 3 | 3 |
| Book NAV/Share(Rs) | 338.24 | 317.96 | 387.36 | 502.57 | 540.16 | 655.38 |
| Core EBITDA Margin(%) | 16.76 | 22.16 | 29.45 | 34.49 | 21.13 | 23.14 |
| EBIT Margin(%) | 16.68 | 22.37 | 28.35 | 33.39 | 16.96 | 18.11 |
| Pre Tax Margin(%) | 12.68 | 18.13 | 26.37 | 31.33 | 13.86 | 15.01 |
| PAT Margin (%) | 7.23 | -8.33 | 19.57 | 23.23 | 10.13 | 11.5 |
| Cash Profit Margin (%) | 14.57 | -0.73 | 24.76 | 27.37 | 16.79 | 18.96 |
| ROA(%) | 3.25 | -3.76 | 12.08 | 17.35 | 4.94 | 5.5 |
| ROE(%) | 5.1 | -6.15 | 20.03 | 27.07 | 7.59 | 8.31 |
| ROCE(%) | 8.04 | 11.32 | 20.65 | 29.71 | 9.76 | 10.02 |
| Receivable days | 78.68 | 84.52 | 66.54 | 60.4 | 82.95 | 78.46 |
| Inventory Days | 113.24 | 115.05 | 83.39 | 77.95 | 129.94 | 130.33 |
| Payable days | 176.08 | 187.04 | 156.77 | 152.08 | 167.52 | 150.5 |
| PER(x) | 16.23 | 0 | 38.35 | 24.93 | 78.26 | 80.93 |
| Price/Book(x) | 0.86 | 1.81 | 7.1 | 6 | 5.73 | 6.14 |
| Dividend Yield(%) | 0 | 0 | 0.15 | 0.13 | 0.1 | 0.07 |
| EV/Net Sales(x) | 1.87 | 2.97 | 7.99 | 6.06 | 8.37 | 9.7 |
| EV/Core EBITDA(x) | 7.46 | 9.89 | 23.77 | 16.11 | 35.33 | 37.84 |
| Net Sales Growth(%) | 0 | 1.69 | 49.16 | 43.78 | -24.7 | 10.67 |
| EBIT Growth(%) | 0 | 36.17 | 88.87 | 69.24 | -61.71 | 18.1 |
| PAT Growth(%) | 0 | -217.01 | 450.24 | 70.53 | -67.13 | 25.52 |
| EPS Growth(%) | 0 | -211.4 | 459.93 | 68.8 | -67.28 | 25.55 |
| Debt/Equity(x) | 0.46 | 0.45 | 0.36 | 0.27 | 0.34 | 0.28 |
| Current Ratio(x) | 1.05 | 1.06 | 1.28 | 1.48 | 1.36 | 1.7 |
| Quick Ratio(x) | 0.6 | 0.58 | 0.78 | 0.85 | 0.73 | 0.99 |
| Interest Cover(x) | 4.17 | 5.28 | 14.33 | 16.28 | 5.47 | 5.85 |
| Total Debt/Mcap(x) | 0.54 | 0.25 | 0.05 | 0.04 | 0.06 | 0.05 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 63.81 | 63.81 | 62.58 | 62.58 | 62.58 | 62.58 | 62.58 | 61.39 | 61.39 | 61.39 |
| FII | 4.58 | 4.51 | 5.2 | 4.88 | 4.61 | 4.63 | 4.25 | 4.36 | 4.31 | 4.28 |
| DII | 8.6 | 8.77 | 9.6 | 9.56 | 10.01 | 10.7 | 11.44 | 12.73 | 12.78 | 13.45 |
| Public | 23.02 | 22.91 | 22.62 | 22.98 | 22.8 | 22.09 | 21.73 | 21.52 | 21.52 | 20.88 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.01 | 7.01 | 6.87 | 6.87 | 6.87 | 6.87 | 6.87 | 6.74 | 6.74 | 6.74 |
| FII | 0.5 | 0.5 | 0.57 | 0.54 | 0.51 | 0.51 | 0.47 | 0.48 | 0.47 | 0.47 |
| DII | 0.94 | 0.96 | 1.05 | 1.05 | 1.1 | 1.18 | 1.26 | 1.4 | 1.4 | 1.48 |
| Public | 2.53 | 2.52 | 2.48 | 2.52 | 2.5 | 2.43 | 2.39 | 2.36 | 2.36 | 2.29 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +11% | +6% | +13% | — |
| Operating Profit CAGR | +20% | -3% | +13% | — |
| PAT CAGR | +26% | -11% | +24% | — |
| Share Price CAGR | -3% | +4% | +27% | — |
| ROE Average | +8% | +14% | +11% | +10% |
| ROCE Average | +10% | +16% | +16% | +15% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 63.81 | 63.81 | 62.58 | 62.58 | 62.58 | 62.58 | 62.58 | 61.39 | 61.39 | 61.39 |
| FII | 4.58 | 4.51 | 5.2 | 4.88 | 4.61 | 4.63 | 4.25 | 4.36 | 4.31 | 4.28 |
| DII | 8.6 | 8.77 | 9.6 | 9.56 | 10.01 | 10.7 | 11.44 | 12.73 | 12.78 | 13.45 |
| Public | 36.19 | 36.19 | 37.42 | 37.42 | 37.42 | 37.42 | 37.42 | 38.61 | 38.61 | 38.61 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 7.01 | 7.01 | 6.87 | 6.87 | 6.87 | 6.87 | 6.87 | 6.74 | 6.74 | 6.74 |
| FII | 0.5 | 0.5 | 0.57 | 0.54 | 0.51 | 0.51 | 0.47 | 0.48 | 0.47 | 0.47 |
| DII | 0.94 | 0.96 | 1.05 | 1.05 | 1.1 | 1.18 | 1.26 | 1.4 | 1.4 | 1.48 |
| Public | 3.98 | 3.98 | 4.11 | 4.11 | 4.11 | 4.11 | 4.11 | 4.24 | 4.24 | 4.24 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 | 10.99 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.